BPMC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.21%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $24,685,047.58

Blueprint Medicines Insider Trading History Chart

Blueprint Medicines Share Price & Price History

^$81.68

▼ -5.43 (-6.23%)

As of 04/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Blueprint Medicines Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/24/2025	Christina Rossi	COO	Sell	2,274	$95.02	$216,075.48	69,266
3/3/2025	Ariel Hurley	Insider	Sell	3,203	$92.62	$296,661.86	18,270
1/21/2025	Christina Rossi	COO	Sell	2,274	$110.14	$250,458.36	67,109
1/21/2025	Jeffrey W. Albers	Director	Sell	15,161	$109.53	$1,660,584.33	152,396
1/21/2025	Kate Haviland	CEO	Sell	1,446	$110.24	$159,407.04	149,378
1/13/2025	Ariel Hurley	Insider	Sell	2,250	$100.00	$225,000.00	14,967
1/13/2025	Jeffrey W. Albers	Director	Sell	5,000	$102.28	$511,400.00	157,557
12/19/2024	Jeffrey W. Albers	Director	Sell	15,000	$89.77	$1,346,550.00	157,557
12/18/2024	Christina Rossi	COO	Sell	2,274	$95.91	$218,099.34	69,383
12/12/2024	Ariel Hurley	Insider	Sell	1,819	$93.26	$169,639.94	14,967
11/29/2024	Kate Haviland	CEO	Sell	2,353	$96.60	$227,299.80	150,824
11/27/2024	Christina Rossi	COO	Sell	2,274	$95.10	$216,257.40	71,657
10/3/2024	Fouad Namouni	Insider	Sell	3,633	$89.32	$324,499.56	69,070
8/5/2024	Philina Lee	Insider	Sell	41,913	$93.19	$3,905,872.47	34,729
7/5/2024	Debra Durso-Bumpus	Insider	Sell	3,850	$111.20	$428,120.00	43,763
7/3/2024	Debra Durso-Bumpus	Insider	Sell	8,817	$111.29	$981,243.93	43,763
6/28/2024	Debra Durso-Bumpus	Insider	Sell	333	$111.15	$37,012.95	43,763
6/21/2024	Debra Durso-Bumpus	Insider	Sell	74,034	$104.19	$7,713,602.46	43,763
6/5/2024	Percy H. Carter	Insider	Sell	4,000	$105.13	$420,520.00	41,895
6/3/2024	L. Becker Hewes	Insider	Sell	4,922	$106.43	$523,848.46	31,938
5/31/2024	L. Becker Hewes	Insider	Sell	34,108	$105.91	$3,612,378.28	36,860
5/2/2024	Ariel Hurley	Insider	Sell	1,834	$103.88	$190,515.92	14,913
5/2/2024	Michael Landsittel	CFO	Sell	10,000	$105.00	$1,050,000.00	47,286
3/28/2024	Michael Landsittel	CFO	Sell	5,000	$95.00	$475,000.00	47,286
3/20/2024	Jeffrey W. Albers	Director	Sell	25,073	$87.28	$2,188,371.44	176,050
3/15/2024	Michael Landsittel	CFO	Sell	13,734	$87.78	$1,205,570.52	47,286
3/7/2024	Christina Rossi	COO	Sell	6,070	$90.69	$550,488.30	64,306
3/7/2024	Jeffrey W. Albers	Director	Sell	11,033	$90.69	$1,000,582.77	165,017
3/7/2024	Kate Haviland	CEO	Sell	12,464	$90.69	$1,130,360.16	153,177
3/7/2024	L. Becker Hewes	Insider	Sell	3,097	$90.69	$280,866.93	46,281
3/7/2024	Michael Landsittel	CFO	Sell	5,003	$90.69	$453,722.07	56,020
3/7/2024	Tracey L. Mccain	EVP	Sell	5,194	$90.69	$471,043.86	60,498
3/4/2024	Christopher K. Murray	Insider	Sell	621	$93.65	$58,156.65	36,374
2/28/2024	Christopher K. Murray	Insider	Sell	5,000	$100.00	$500,000.00	24,495
1/25/2024	Jeffrey W. Albers	Director	Sell	25,000	$81.91	$2,047,750.00	176,050
12/22/2023	Ariel Hurley	Insider	Sell	714	$90.00	$64,260.00	14,324
12/7/2023	Christopher K. Murray	Insider	Sell	5,000	$75.00	$375,000.00	24,495
12/4/2023	Christopher K. Murray	Insider	Sell	600	$71.43	$42,858.00	24,495
11/30/2023	Jeffrey W. Albers	Director	Sell	5,000	$70.55	$352,750.00	176,050
11/24/2023	Jeffrey W. Albers	Director	Sell	15,000	$67.51	$1,012,650.00	176,050
11/3/2023	Jeffrey W. Albers	Director	Sell	1,485	$60.13	$89,293.05	176,050
11/1/2023	Jeffrey W. Albers	Director	Sell	3,881	$60.02	$232,937.62	176,050
10/26/2023	Christopher K. Murray	Insider	Sell	600	$56.40	$33,840.00	25,095
10/4/2023	Fouad Namouni	Insider	Sell	3,769	$48.06	$181,138.14	62,080
9/28/2023	Jeffrey W. Albers	Director	Sell	6,898	$50.17	$346,072.66	176,050
8/25/2023	Jeffrey W. Albers	Director	Sell	10,000	$50.16	$501,600.00	176,050
6/5/2023	Percy H. Carter	Insider	Sell	2,307	$52.06	$120,102.42	38,117
3/6/2023	Christina Rossi	COO	Sell	3,059	$45.67	$139,704.53	55,376
3/6/2023	Christopher K. Murray	Insider	Sell	1,875	$45.68	$85,650.00	25,695
3/6/2023	Jeffrey W. Albers	Director	Sell	9,793	$45.67	$447,246.31	173,450
3/6/2023	Kate Haviland	CEO	Sell	6,640	$45.69	$303,381.60	125,641
3/6/2023	Michael Landsittel	CFO	Sell	3,007	$45.68	$137,359.76	48,523
3/6/2023	Tracey L. Mccain	EVP	Sell	3,322	$45.68	$151,748.96	52,666
12/5/2022	Jeffrey W. Albers	Director	Sell	20,000	$50.09	$1,001,800.00	183,243
11/3/2022	Christina Rossi	COO	Sell	533	$45.24	$24,112.92	43,435
11/3/2022	Kate Haviland	CEO	Buy	1,100	$43.98	$48,378.00	92,281
10/4/2022	Fouad Namouni	Insider	Sell	3,477	$67.30	$234,002.10	52,797
8/24/2022	Debra Durso-Bumpus	Insider	Sell	5,000	$75.11	$375,550.00	40,836
8/22/2022	Jeffrey W. Albers	Director	Sell	8,410	$70.54	$593,241.40	183,243
8/19/2022	Jeffrey W. Albers	Director	Sell	1,590	$70.02	$111,331.80	183,243
8/16/2022	Jeffrey W. Albers	Director	Sell	20,000	$68.41	$1,368,200.00	183,243
8/8/2022	Jeffrey W. Albers	Director	Sell	10,000	$70.07	$700,700.00	183,243
8/4/2022	Christopher K. Murray	SVP	Sell	2,500	$60.44	$151,100.00	21,320
6/6/2022	Percy H. Carter	Insider	Sell	1,908	$59.76	$114,022.08	28,685
4/6/2022	Jeffrey W. Albers	CEO	Sell	5,000	$70.11	$350,550.00	183,243
3/17/2022	George Demetri	Director	Sell	10	$58.56	$585.60	5,812

See Full Table

SEC Filings (Institutional Ownership Changes) for Blueprint Medicines (NASDAQ:BPMC)

Institutional Buying and Selling by Quarter

Blueprint Medicines Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/18/2025	California State Teachers Retirement System	59,259	$5.17M	0.0%	+4.9%	0.093%
2/27/2025	Jefferies Financial Group Inc.	47,500	$4.14M	0.0%	-12.2%	0.074%
2/20/2025	Mackenzie Financial Corp	14,177	$1.24M	0.0%	+99.6%	0.022%
2/19/2025	GF Fund Management CO. LTD.	1,334	$0.12M	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	239,946	$20.93M	0.0%	+5.3%	0.378%
2/17/2025	Voloridge Investment Management LLC	213,697	$18.64M	0.1%	-25.7%	0.336%
2/17/2025	Woodline Partners LP	540,192	$47.12M	0.3%	+19.1%	0.850%
2/17/2025	Zimmer Partners LP	33,650	$2.94M	0.1%	+59.5%	0.053%
2/17/2025	Tema Etfs LLC	22,474	$1.96M	0.8%	N/A	0.035%
2/17/2025	Sherbrooke Park Advisers LLC	3,374	$0.29M	0.1%	+8.4%	0.005%
2/17/2025	Rafferty Asset Management LLC	88,891	$7.75M	0.0%	-24.0%	0.140%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	1,220	$0.11M	0.0%	N/A	0.002%
2/17/2025	Point72 Asset Management L.P.	166,418	$14.52M	0.0%	N/A	0.262%
2/17/2025	Point72 Europe London LLP	43,568	$3.80M	0.2%	N/A	0.069%
2/17/2025	Point72 Hong Kong Ltd	2,218	$0.19M	0.0%	N/A	0.003%
2/17/2025	Polar Capital Holdings Plc	626,379	$54.63M	0.3%	-28.6%	0.986%
2/17/2025	ProShare Advisors LLC	20,915	$1.82M	0.0%	+33.9%	0.033%
2/17/2025	Prosight Management LP	67,000	$5.84M	1.6%	+42.3%	0.105%
2/17/2025	Man Group plc	103,919	$9.06M	0.0%	-80.0%	0.164%
2/17/2025	Nuveen Asset Management LLC	419,190	$36.56M	0.0%	+49.2%	0.660%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	20,133	$1.76M	0.1%	-9.5%	0.032%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	42,855	$3.74M	0.0%	+1.4%	0.067%
2/17/2025	Lazard Asset Management LLC	1,378	$0.12M	0.0%	-86.4%	0.002%
2/17/2025	Integral Health Asset Management LLC	275,000	$23.99M	2.0%	-5.2%	0.433%
2/17/2025	Jacobs Levy Equity Management Inc.	648,660	$56.58M	0.2%	+30.8%	1.021%
2/17/2025	Jefferies Financial Group Inc.	47,500	$4.14M	0.0%	-12.2%	0.075%
2/17/2025	Gotham Asset Management LLC	3,545	$0.31M	0.0%	N/A	0.006%
2/17/2025	Graham Capital Management L.P.	25,260	$2.20M	0.0%	+48.8%	0.040%
2/17/2025	Granahan Investment Management LLC	141,890	$12.38M	0.5%	+8.2%	0.223%
2/17/2025	Ensign Peak Advisors Inc	275,424	$24.02M	0.0%	-15.6%	0.434%
2/17/2025	Fred Alger Management LLC	25,623	$2.24M	0.0%	-22.6%	0.040%
2/17/2025	Frontier Capital Management Co. LLC	105,130	$9.17M	0.1%	+401.6%	0.165%
2/17/2025	Deutsche Bank AG	261,363	$22.80M	0.0%	+9.4%	0.411%
2/17/2025	DAFNA Capital Management LLC	149,763	$13.06M	3.3%	+23.0%	0.236%
2/17/2025	Cetera Investment Advisers	6,861	$0.60M	0.0%	-3.4%	0.011%
2/17/2025	Brevan Howard Capital Management LP	17,751	$1.55M	0.0%	+48.5%	0.028%
2/17/2025	Bridgefront Capital LLC	3,603	$0.31M	0.1%	-40.6%	0.006%
2/17/2025	Captrust Financial Advisors	8,331	$0.73M	0.0%	-53.5%	0.013%
2/17/2025	Avidity Partners Management LP	176,600	$15.40M	1.5%	-43.9%	0.278%
2/17/2025	Brown Advisory Inc.	578,780	$50.48M	0.1%	-2.5%	0.911%
2/17/2025	Balyasny Asset Management L.P.	102,486	$8.94M	0.0%	+90.7%	0.161%
2/17/2025	Bayesian Capital Management LP	18,579	$1.62M	0.2%	N/A	0.029%
2/17/2025	Bank of America Corp DE	395,031	$34.46M	0.0%	-4.0%	0.622%
2/17/2025	Ameriprise Financial Inc.	338,115	$29.49M	0.0%	+4.2%	0.532%
2/17/2025	Algert Global LLC	112,172	$9.78M	0.2%	+21.6%	0.177%
2/17/2025	Alkeon Capital Management LLC	800,628	$69.83M	0.1%	+11.4%	1.260%
2/17/2025	Ally Bridge Group NY LLC	55,892	$4.88M	4.1%	-47.3%	0.088%
2/14/2025	Comerica Bank	13,115	$1.14M	0.0%	+411.5%	0.021%
2/14/2025	PDT Partners LLC	3,098	$0.27M	0.0%	N/A	0.005%
2/14/2025	Schonfeld Strategic Advisors LLC	13,200	$1.15M	0.0%	-77.8%	0.021%
2/14/2025	AQR Capital Management LLC	144,693	$12.62M	0.0%	+26.9%	0.228%
2/14/2025	Emerald Mutual Fund Advisers Trust	268,978	$23.46M	1.4%	-6.8%	0.423%
2/14/2025	Northern Trust Corp	608,392	$53.06M	0.0%	+9.5%	0.958%
2/14/2025	The Manufacturers Life Insurance Company	176,484	$15.39M	0.0%	+17.7%	0.278%
2/14/2025	Tudor Investment Corp ET AL	8,100	$0.71M	0.0%	-208.0%	0.013%
2/14/2025	Aquatic Capital Management LLC	47,602	$4.15M	0.1%	+11.7%	0.075%
2/14/2025	Susquehanna Fundamental Investments LLC	56,245	$4.91M	0.1%	N/A	0.089%
2/14/2025	Virtus ETF Advisers LLC	3,777	$0.33M	0.1%	+22.0%	0.006%
2/14/2025	Nebula Research & Development LLC	7,759	$0.68M	0.1%	+18.8%	0.012%
2/14/2025	Lord Abbett & CO. LLC	335,043	$29.22M	0.1%	-71.6%	0.527%
2/14/2025	Oberweis Asset Management Inc.	75,000	$6.54M	0.3%	N/A	0.118%
2/14/2025	Voya Investment Management LLC	205,391	$17.91M	0.0%	+11.8%	0.323%
2/14/2025	Syon Capital LLC	2,347	$0.21M	0.0%	N/A	0.004%
2/14/2025	Hood River Capital Management LLC	879,932	$76.75M	1.1%	+30.9%	1.385%
2/14/2025	T. Rowe Price Investment Management Inc.	697,027	$60.80M	0.0%	-6.9%	1.097%
2/14/2025	Price T Rowe Associates Inc. MD	5,679,089	$495.33M	0.1%	+5.4%	8.939%
2/14/2025	Dark Forest Capital Management LP	8,579	$0.75M	0.1%	-17.1%	0.014%
2/14/2025	Diadema Partners LP	64,193	$5.60M	2.4%	N/A	0.101%
2/14/2025	Hsbc Holdings PLC	20,019	$1.73M	0.0%	-37.1%	0.032%
2/14/2025	Avoro Capital Advisors LLC	1,185,000	$103.36M	1.5%	N/A	1.865%
2/14/2025	Rock Springs Capital Management LP	1,096,899	$95.67M	3.6%	+42.7%	1.727%
2/14/2025	Tower Research Capital LLC TRC	7,265	$0.63M	0.0%	+903.5%	0.011%
2/14/2025	Thematics Asset Management	826	$72K	0.0%	N/A	0.001%
2/14/2025	MetLife Investment Management LLC	38,099	$3.32M	0.0%	+5.0%	0.060%
2/14/2025	Dimensional Fund Advisors LP	40,208	$3.51M	0.0%	+3.1%	0.063%
2/14/2025	First Trust Advisors LP	53,705	$4.68M	0.0%	-2.0%	0.085%
2/14/2025	Alpha DNA Investment Management LLC	5,098	$0.45M	0.2%	N/A	0.008%
2/13/2025	CANADA LIFE ASSURANCE Co	6,220	$0.54M	0.0%	-17.8%	0.010%
2/13/2025	Canada Pension Plan Investment Board	19,800	$1.73M	0.0%	N/A	0.031%
2/13/2025	Marshall Wace LLP	161,882	$14.12M	0.0%	-51.5%	0.255%
2/13/2025	Guggenheim Capital LLC	13,139	$1.15M	0.0%	-22.1%	0.021%
2/13/2025	XTX Topco Ltd	11,146	$0.97M	0.1%	+406.6%	0.018%
2/13/2025	Barclays PLC	189,127	$16.49M	0.0%	+10.5%	0.298%
2/13/2025	Summit Investment Advisors Inc.	6,652	$0.58M	0.5%	+4.4%	0.010%
2/13/2025	Synovus Financial Corp	24,528	$2.14M	0.0%	+2.0%	0.039%
2/13/2025	Granite Investment Partners LLC	23,255	$2.03M	0.1%	N/A	0.037%
2/13/2025	Covestor Ltd	973	$85K	0.1%	+62.7%	0.002%
2/13/2025	Kennedy Capital Management LLC	4,564	$0.40M	0.0%	+19.6%	0.007%
2/13/2025	F M Investments LLC	31,313	$2.73M	0.1%	N/A	0.049%
2/13/2025	Raymond James Financial Inc.	241,966	$21.10M	0.0%	N/A	0.381%
2/13/2025	Martingale Asset Management L P	15,993	$1.40M	0.0%	+2.5%	0.025%
2/13/2025	Renaissance Technologies LLC	126,300	$11.02M	0.0%	-27.6%	0.199%
2/13/2025	Legal & General Group Plc	94,516	$8.24M	0.0%	-2.9%	0.149%
2/13/2025	Invesco Ltd.	960,437	$83.77M	0.0%	+6.7%	1.512%
2/13/2025	Cerity Partners LLC	3,298	$0.29M	0.0%	N/A	0.005%
2/13/2025	FMR LLC	2,247,679	$196.04M	0.0%	-50.2%	3.538%
2/13/2025	Federated Hermes Inc.	156,284	$13.63M	0.0%	+1.9%	0.246%
2/13/2025	Russell Investments Group Ltd.	125,902	$10.98M	0.0%	+15.5%	0.198%
2/13/2025	Envestnet Asset Management Inc.	32,115	$2.80M	0.0%	+13.1%	0.051%
2/13/2025	Dynamic Technology Lab Private Ltd	2,436	$0.21M	0.0%	N/A	0.004%

Data available starting January 2016

See Full Table

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of indolent SM, and other mast cell disorders. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered thyroid carcinoma, and medullary thyroid carcinoma; BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $81.68

$80.08

$86.00

50 Day Range

MA: $95.52

$81.68

$114.47

52 Week Range

Now: $81.68

$80.08

$121.90

Volume

1,492,586 shs

Average Volume

742,386 shs

Market Capitalization

$5.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75

Who are the company insiders with the largest holdings of Blueprint Medicines?: Blueprint Medicines' top insider investors include:
Jeffrey W Albers (Director)
Kate Haviland (CEO)
Christina Rossi (COO)
Fouad Namouni (Insider)
Tracey L Mccain (EVP)
Michael Landsittel (CFO)
L Becker Hewes (Insider)
Debra Durso-Bumpus (Insider)
Percy H Carter (Insider)
Christopher K Murray (Insider)
Philina Lee (Insider)
Ariel Hurley (Insider)
Learn More about top insider investors at Blueprint Medicines.